These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2532072

  • 1. Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients.
    Buzaid AC, Alberts DS, Einspahr J, Mosley K, Peng YM, Tutsch K, Spears CP, Garewal HS.
    Cancer Chemother Pharmacol; 1989; 25(2):124-30. PubMed ID: 2532072
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell lines.
    Tsai CM, Gazdar AF, Allegra C, Perng RP, Kramer BS.
    Int J Cancer; 1990 Jul 15; 46(1):101-5. PubMed ID: 2163987
    [Abstract] [Full Text] [Related]

  • 3. Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy.
    Lehman NL, Danenberg PV.
    Cancer Chemother Pharmacol; 2000 Jul 15; 45(2):142-8. PubMed ID: 10663629
    [Abstract] [Full Text] [Related]

  • 4. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
    Koning GA, Gorter A, Scherphof GL, Kamps JA.
    Br J Cancer; 1999 Aug 15; 80(11):1718-25. PubMed ID: 10468287
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate.
    Goel R, Sanga R, Howell SB.
    Cancer Chemother Pharmacol; 1989 Aug 15; 25(3):167-72. PubMed ID: 2598406
    [Abstract] [Full Text] [Related]

  • 6. Fluorodeoxyuridine with continuous leucovorin infusion. A phase II clinical trial in patients with metastatic colorectal cancer.
    Levin RD, Gordon JH.
    Cancer; 1993 Nov 15; 72(10):2895-901. PubMed ID: 8221555
    [Abstract] [Full Text] [Related]

  • 7. Effects of FUdR on primary-cultured colon carcinomas metastatic to the liver.
    Schroy PC, Cohen A, Winawer SJ, Friedman EA.
    J Surg Oncol; 1990 Dec 15; 45(4):217-23. PubMed ID: 2147452
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P.
    Cancer; 1992 Jan 15; 69(2):327-34. PubMed ID: 1303612
    [Abstract] [Full Text] [Related]

  • 9. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer.
    Keane TE, Rosner GL, Gingrich JR, Poulton SH, Walther PJ.
    J Urol; 1991 Nov 15; 146(5):1418-24. PubMed ID: 1942313
    [Abstract] [Full Text] [Related]

  • 10. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
    Koning GA, Kamps JA, Scherphof GL.
    Cancer Detect Prev; 2002 Nov 15; 26(4):299-307. PubMed ID: 12430634
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL, Fischer PH.
    Cancer Res; 1985 Jul 15; 45(7):2967-72. PubMed ID: 4005834
    [Abstract] [Full Text] [Related]

  • 12. Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.
    Köhne CH, Hiddemann W, Schüller J, Weiss J, Lohrmann HP, Schmitz-Hübner U, Bodenstein H, Schöber C, Wilke H, Grem J.
    J Clin Oncol; 1995 May 15; 13(5):1201-8. PubMed ID: 7738622
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 15; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.
    Grem JL, Fischer PH.
    Pharmacol Ther; 1989 Nov 15; 40(3):349-71. PubMed ID: 2646650
    [Abstract] [Full Text] [Related]

  • 15. 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.
    Maehara Y, Sakaguchi Y, Takahashi I, Yoshida M, Kusumoto H, Masuda H, Sugimachi K.
    Cancer Chemother Pharmacol; 1992 Nov 15; 29(4):257-60. PubMed ID: 1537070
    [Abstract] [Full Text] [Related]

  • 16. The effect of liver macrophages on in vitro cytolytic activity of 5FU and FUdR on colon carcinoma cells: evidence of macrophage activation.
    Daemen T, Regts J, Morselt H, Scherphof GL.
    Int J Immunopharmacol; 1992 Jul 15; 14(5):857-64. PubMed ID: 1387390
    [Abstract] [Full Text] [Related]

  • 17. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
    Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC.
    J Natl Cancer Inst; 1991 Mar 20; 83(6):423-8. PubMed ID: 1825674
    [Abstract] [Full Text] [Related]

  • 18. Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survival.
    Port JL, Ng B, Ellis JL, Nawata S, Lenert JT, Burt ME.
    Ann Thorac Surg; 1996 Sep 20; 62(3):848-52. PubMed ID: 8784018
    [Abstract] [Full Text] [Related]

  • 19. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 20. In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugates.
    Goerlach A, Krauer KG, McKenzie IF, Pietersz GA.
    Bioconjug Chem; 1991 Feb 15; 2(2):96-101. PubMed ID: 1831049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.